Seeing Is Believing
with an average price target of $120.96. This is a potential upside of $7.39 (6.51%) from yesterday's end of day stock price of $113.57.
Spark Therapeutics's activity chart (see below) currently has 119 price targets and 84 ratings on display.
Analysts average stock forecasts to be materialized ratio is 96.22% with an average time for these price targets to be met of 197.24 days.
Most recent stock forecast was given by PHIL NADEAU from TD COWEN on 25-Mar-2019. First documented stock forecast 24-Feb-2015.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 25-Mar-2019
$80
6 years 9 months 16 days ago
(25-Mar-2019)
5/5 (100%)
$23.99 (42.83%)
375
Buy
Since 25-Mar-2019
$74
$-39.57 (-34.84%)
6 years 9 months 16 days ago
(25-Mar-2019)
6/7 (85.71%)
$-39.53 (-34.82%)
203
Hold
Since 27-Feb-2019
$65
$-48.57 (-42.77%)
$65
6 years 10 months 14 days ago
(27-Feb-2019)
5/6 (83.33%)
$-48.4 (-42.68%)
212
Hold
Since 26-Feb-2019
$72
6 years 10 months 15 days ago
(26-Feb-2019)
6/6 (100%)
$16.24 (29.12%)
280
Buy
Since 09-Oct-2018
$70
6 years 10 months 16 days ago
(25-Feb-2019)
1/1 (100%)
$20.66 (41.87%)
139
What is ONCE (Spark Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ONCE (Spark Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ONCE (Spark Therapeutics)?
Which analyst is the currently most bullish on ONCE (Spark Therapeutics)?
Which analyst is the currently most reserved on ONCE (Spark Therapeutics)?